List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 34 studies with search of: dexamethasone ES
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure
Condition: Multiple Myeloma
Intervention: Drug: velcade
2 Recruiting QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
Condition: Multiple Myeloma
Interventions: Procedure: Maintenance with lower doses of lenalidomide and dexamethasone;   Procedure: Observation
3 Recruiting R-BMD GELTAMO Relapsed Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Rituximab, Bendamustine, Mitoxantrone, Dexametasona
4 Recruiting MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: dexamethasone;   Drug: Fludarabine;   Drug: Melphalan
5 Recruiting Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Panobinostat;   Drug: Bortezomib;   Drug: Dexamethasone;   Drug: Placebo
6 Completed GEM05 for Patients With Multiple Myeloma Under 65 Years
Condition: Multiple Myeloma
Interventions: Drug: VBMCP/VBAD/Velcade;   Drug: Thalidomide/Dexamethasone;   Drug: Velcade/Thalidomide/Dexamethasone
7 Completed VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Velcade/Dexamethasone
8 Recruiting Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide and low-dose dexamethasone;   Drug: Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles;   Drug: Melphalan, Prednisone and Thalidomide
9 Active, not recruiting A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: CC-5013
10 Active, not recruiting Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Thalidomide
11 Recruiting Aplidin - Dexamethasone in Relapsed/Refractory Myeloma
Condition: Relapsed/Refractory Multiple Myeloma
Interventions: Drug: plitidepsin + dexamethasone;   Drug: dexamethasone
12 Completed A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: Oral Casopitant (GW679769);   Drug: IV Casopitant (GW679769);   Drug: IV ondansetron hydrochloride;   Drug: Oral dexamethasone
13 Recruiting Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
Condition: Multiple Myeloma
Interventions: Drug: Dexamethasone;   Drug: bortezomib;   Drug: Cyclophosphamide;   Drug: Lenalidomide
14 Active, not recruiting Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide and Dexamethasone;   Drug: Dexamethasone
15 Completed Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Casopitant (GW679769) oral tablets;   Drug: Casopitant (GW679769) intravenous;   Drug: Dexamethasone intravenous;   Drug: Ondansetron oral tablets
16 Completed Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: GW679769;   Drug: Dexamethasone;   Drug: Ondansetron Hydrochloride
17 Recruiting Treatment of High Risk Adult Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine;   Drug: Daunorubicin;   Drug: Prednisone;   Drug: Mitoxantrone;   Drug: Cytosine Arabinoside;   Drug: Dexamethasone;   Drug: Methotrexate (MTX);   Drug: Cytarabine;   Drug: ASP;   Drug: Mercaptopurine;   Drug: Teniposide;   Drug: Hydrocortisone
18 Active, not recruiting A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: pemetrexed;   Dietary Supplement: Folic acid;   Dietary Supplement: Folic Acid;   Dietary Supplement: Vitamin B12;   Drug: dexamethasone
19 Completed PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: bortezomib
20 Completed A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
Condition: Multiple Myeloma
Intervention: Drug: bortezomib

Previous Page Studies Shown (1-20) Next Page (21-34)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services